Journal
/
/
Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
JoVE Journal
Pesquisa do Câncer
É necessária uma assinatura da JoVE para visualizar este conteúdo.  Faça login ou comece sua avaliação gratuita.
JoVE Journal Pesquisa do Câncer
Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
DOI:

13:38 min

January 18, 2017

, , , ,

Capítulos

  • 00:05Título
  • 01:13Synthesis of Aspirin-fumarate Prodrug, GTCpFE
  • 06:10Inhibiting the NFκB Activity with GTCpFE in Breast Cancer Cells
  • 07:22Inhibiting Breast Cancer Stem Cells with GTCpFE In Vitro
  • 10:11Results: GTCpFE Inhibits the NFκB Pathway, Mammosphere Formation, and the CD44+CD24 Immunophenotype in Breast Cancer Cells
  • 11:49Conclusion

Summary

Tadução automática

This procedure will demonstrate how we synthesized and characterized the anti-NFκB and anti-cancer stem cell activity of an aspirin-fumarate prodrug.

Vídeos Relacionados

Read Article